Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical epidemiology].

K Ohyashiki1

  • 1First Department of Internal Medicine, Tokyo Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

The incidence of chronic myeloid leukemia (CML) in Japan is approximately 5/100,000 annually, potentially increasing. Early detection through annual exams reveals changing CML patient demographics and disease characteristics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Two Additional Acute Nonlymphocytic Leukemia Patients with a Sole Chromosome Abnormality of Trisomy 4.

Leukemia & lymphoma·2016
Same author

Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.

Transplant infectious disease : an official journal of the Transplantation Society·2014
Same author

A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.

Bone marrow transplantation·2014
Same author

Monosomal karyotype in MDS: explaining the poor prognosis?

Leukemia·2013
Same author

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders.

Blood cancer journal·2012

Area of Science:

  • Hematology
  • Oncology
  • Epidemiology

Context:

  • Chronic myeloid leukemia (CML) incidence in Japan is estimated at 5/100,000 per year, representing about 15% of all leukemia cases.
  • While CML rates in Japan appear lower than in Caucasian populations, a gradual increase may occur.
  • Historical etiological factors include atomic bomb radiation exposure, but other causes remain unclear.

Purpose:

  • To investigate the epidemiological trends and changing characteristics of chronic myeloid leukemia (CML) in Japan.
  • To understand the molecular basis of CML, specifically the t(9;22) translocation.
  • To analyze how increased early detection through annual examinations impacts CML patient profiles.

Summary:

  • CML occurs at an estimated rate of 5/100,000 annually in Japan, with potential for increase.

Related Experiment Videos

  • Molecular studies have elucidated the t(9;22) anomaly as central to CML pathogenesis and classification.
  • Modern diagnostic practices identify CML earlier, often presenting with less severe symptoms like absent splenomegaly and varied karyotypes alongside Philadelphia chromosome presence.

    • Impact:

    • Findings suggest evolving epidemiological patterns in CML within the Japanese population.
    • Early diagnosis may lead to altered disease presentation and severity compared to historical cohorts.
    • This research highlights the need for ongoing surveillance and updated understanding of CML in Japan.